Skip to content
Sign in

STE · NYSE

STERIS (STE) Stock Price & Fundamentals

$533.52+0.44%+$2.35End-of-day price as of Oct 9, 2026

STERIS (STE) closed at $533.52 on Oct 9, 2026, up 0.44% from the previous close of $531.17.

Share price, past year

1Y +19.76%

52-week range $436.82 – $533.52. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$533.52
Sep 30, 2026$519.45
Aug 31, 2026$516.52
Jul 31, 2026$513.46
Jun 30, 2026$522.10
May 29, 2026$503.77
Apr 30, 2026$482.15
Mar 31, 2026$463.33
Feb 27, 2026$481.10
Jan 30, 2026$488.37
Dec 31, 2025$481.53
Nov 28, 2025$466.73
Oct 31, 2025$444.90

Key statistics

Market cap
$52.02B
P/E (TTM)
67.3
EPS (TTM)
$7.93
Revenue (TTM)
$6.04B
Net income (TTM)
$805.00M
Shares outstanding
97.5M
Dividend yield
0.47%
52-week range
$436.82 – $533.52

STERIS's market cap is $52.02B, based on a share price of $533.52 and 97.5M shares outstanding as of Jun 30, 2026.

Financials

STERIS reported revenue of $5.94B for fiscal 2026, up 8.73% from fiscal 2025.

STERIS earned net income of $782.30M in fiscal 2026, a net margin of 13.2%.

Fiscal 2026 revenue was the highest in the 10 years shown.

Annual revenue

FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Annual revenue by fiscal year; the table below lists the values.
STERIS annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2026ended Mar 31, 2026$5.94B+8.7%$782.30M13.2%$7.93$972.40M
FY2025ended Mar 31, 2025$5.46B+6.2%$614.60M11.3%$6.20$778.00M
FY2024ended Mar 31, 2024$5.14B+13.3%$378.20M7.4%$3.81$613.00M
FY2023ended Mar 31, 2023$4.54B+7.4%$107.03M2.4%$1.07$394.98M
FY2022ended Mar 31, 2022$4.22B+35.9%$243.89M5.8%$2.48$397.25M
FY2021ended Mar 31, 2021$3.11B+2.5%$397.40M12.8%$4.63$450.38M
FY2020ended Mar 31, 2020$3.03B+8.9%$407.66M13.5%$4.76$376.04M
FY2019ended Mar 31, 2019$2.78B+6.2%$303.72M10.9%$3.55$349.79M
FY2018ended Mar 31, 2018$2.62B+0.3%$290.92M11.1%$3.39$292.18M
FY2017ended Mar 31, 2017$2.61B—$109.97M4.2%$1.28$251.19M
STERIS quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q1 FY2027ended Jun 30, 2026$1.49B$200.10M—
Q4 FY2026ended Mar 31, 2026$1.59B$220.10M$2.24
Q3 FY2026ended Dec 31, 2025$1.50B$192.90M$1.96
Q2 FY2026ended Sep 30, 2025$1.46B$191.90M$1.94
Q1 FY2026ended Jun 30, 2025$1.39B$177.40M$1.79
Q4 FY2025ended Mar 31, 2025$1.48B$145.70M$1.48
Q3 FY2025ended Dec 31, 2024$1.37B$173.50M$1.75
Q2 FY2025ended Sep 30, 2024$1.33B$150.00M$1.51

Company profile

Name
STERIS plc
Ticker
STE
Exchange
NYSE
Industry (SEC SIC)
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Headquarters
70 Sir John Rogerson'S Quay, Dublin, L2 2
Incorporated in
L2
Fiscal year ends
March
SEC CIK
0001757898

Recent SEC filings

Frequently asked questions

What is STERIS's stock price?

STERIS (STE) closed at $533.52 on Oct 9, 2026, up 0.44% from the previous close of $531.17.

What is STERIS's market cap?

STERIS's market cap is $52.02B, based on a share price of $533.52 and 97.5M shares outstanding as of Jun 30, 2026.

How much revenue does STERIS make?

STERIS reported revenue of $5.94B for fiscal 2026, up 8.73% from fiscal 2025.

What is STE's P/E ratio?

STERIS's price-to-earnings ratio is 67.3, based on trailing twelve-month diluted EPS of $7.93.

Does STERIS pay a dividend?

Yes. STERIS declared $2.52 per share in dividends over the last four quarters, a yield of 0.47%.

Sources and methodology

Fundamentals come from STERIS plc's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures